Motivational Instant Messaging and E-diabetes Prevention Programme for High Risk of Type 2 Diabetes
NCT ID: NCT02919397
Last Updated: 2018-08-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2016-10-01
2018-07-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
NCT03039569
Diabetes Prevention Using SMS Technology
NCT01795833
Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes Distress
NCT05941000
Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city Patients
NCT01945996
Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
NCT06375460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The intervention will consist of a wearable technology and a smartphone application made available for a 12 month period. 22 online multimedia sessions targeting diet, physical activity and mental resilience delivered via the smartphone application. Motivational messaging based on the diabetes prevention module content and biofeedback will be sent to participants via the application.
The control group will receive the wearable technology and will have access to a smartphone application detailing their activity. Participants will be directed to the same educational material as is made available via the multimedia sessions, but will not receive motivational messages.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
If participants are allocated to the intervention group, participants will receive the wearable technology and access to the smartphone application. Motivational messages based on diabetes prevention programme content, and biofeedback messages based on physical activity data provided via the wearable technology, will be received by participants via the application. The diabetes prevention programme educational material will be available via the application.
Wearable technology
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Diabetes Prevention Programme educational material
Educational material accessed through smartphone application
Motivational messaging
Messages sent via smartphone application
Control
If participants are allocated to the control group, participants will receive the wearable technology and will be able to access their activity data via the smartphone application. Participants will also have have access to the diabetes prevention programme educational material via the application. Participants will not receive motivational messages related to the education content or activity data.
Wearable technology
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Diabetes Prevention Programme educational material
Educational material accessed through smartphone application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wearable technology
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Diabetes Prevention Programme educational material
Educational material accessed through smartphone application
Motivational messaging
Messages sent via smartphone application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI≥25 kg/m²
* Fluent in conversational English
* Permanent resident in Lambeth, Southwark or Lewisham
* Ownership of a smartphone (iPhone or Android only) for communication defined as logging on at least once/day to the internet
* Ambulatory.
Exclusion Criteria
* Pregnancy or planning pregnancy during the duration of the study
* Severe mental illness (severe depression, psychosis, bipolar affective disorder, dementia, learning difficulties, substance problem use or dependence)
* Severe physical disability e.g. that would prevent any increased uptake of physical exercise
* Advanced active disease such as cancer or heart failure
* Any other condition which requires glucose altering drugs
* Morbid obesity (BMI ≥50 kg/m²)
* Current participation in a weight loss programme.
When in doubt the investigators will seek the GP opinion and approval.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Khalida Ismail
Role: PRINCIPAL_INVESTIGATOR
King's College London
References
Explore related publications, articles, or registry entries linked to this study.
Staite E, Bayley A, Al-Ozairi E, Stewart K, Hopkins D, Rundle J, Basudev N, Mohamedali Z, Ismail K. A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Jul 15;8(7):e15448. doi: 10.2196/15448.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
197384
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.